3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...
Join Veristat and other Clinical Operations Executives from pharmaceutical, biotech and other healthcare firms at The 7th Annual SCOPE Summit, taking place February 23-25, 2016 in Miami, FL. This event features three days of in-depth discussions focused on the challenges related to each aspect of clinical trial planning and management including:
SCHEDULE A MEETING
Veristat will be sending a few members of its Clinical Operations team to the event who will be available to speak with you to discuss your goals for 2016. It is our goal to help you advance your clinical trials and regulatory submissions so that your therapies can help the patients who need them.
Brenda Baxter, RN
Director, Clinical Monitoring

Martha Plaza
Director, Project Management
In addition, our Director of Development Eric Monroe will be at the event. Reach out today to schedule a meeting with us at the event or anytime that works for you!
LEARN MORE ABOUT VERISTAT
Click to learn more about Veristat’s Monitoring and Project Management services.
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...
9 min read
Apr 6, 2026 Veristat Blog
March 2026 regulatory updates underscore newly published final and draft guidances focused on real-world data, safety...